Call for Abstract

31st Annual Congress on Vaccines, Clinical Trials & B2B, will be organized around the theme “Vaccines paradigms: Global resilience to Disease”

Vaccines & Clinical Trials 2018 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Vaccines & Clinical Trials 2018

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 1-1Vaccine Immunoinformatics
  • Track 1-2Research trends in development of Vaccines for Zika Virus
  • Track 1-3Immunological challenges
  • Track 1-4Vaccine Management & Quality Assurance
  • Track 1-5Vaccines Research in USA
  • Track 2-1Rotavirus Vaccine
  • Track 2-2OPV Vaccine
  • Track 2-3Smallpox Vaccine
  • Track 2-4Rubella Vaccine
  • Track 2-5Influenza vaccines
  • Track 2-6Chickenpox Vaccine
  • Track 2-7Cholera Vaccine
  • Track 2-8Measles Vaccines
  • Track 2-9Meningococcal /Menactra Vaccines
  • Track 2-10Bordetella Vaccine
  • Track 2-11Pneumonia Vaccines
  • Track 2-12Zoster vaccine
  • Track 3-1Childhood Travel Immunization
  • Track 3-2Polio Vaccine
  • Track 3-3Infant Immunization scheduling
  • Track 3-4MMR vaccine
  • Track 4-1Therapeutic cancer vaccines
  • Track 4-2Feline Leukemia Vaccines
  • Track 4-3Cervical Cancer Vaccine
  • Track 4-4Gene-therapy
  • Track 4-5Cancer Vaccines research
  • Track 4-6Preventive cancer vaccines
  • Track 5-1Live attenuated vaccines
  • Track 5-2Preventive HIV Vaccines
  • Track 5-3Recombinant sub-unit vaccines
  • Track 5-4Peptide vaccines
  • Track 5-5DNA Vaccines
  • Track 5-6Emerging Clinical Trials
  • Track 5-7T cell-based vaccines
  • Track 5-8B cell-based vaccines
  • Track 5-9Vaccines against viral toxins
  • Track 6-1Modified live-virus vaccines for oral immunization of wildlife
  • Track 6-2Vaccines for parenteral use
  • Track 6-3Vaccines for Livestock Diseases
  • Track 7-1TB vaccines
  • Track 7-2Diphtheria vaccines
  • Track 7-3Tetanus vaccines
  • Track 7-4Pertussis vaccines
  • Track 7-5Typhoid vaccines
  • Track 7-6Cholera vaccines
  • Track 8-1Mumps, measles and rubella/MMR Vaccines
  • Track 8-2Live attenuated vaccines
  • Track 8-3Rotavirus Vaccine
  • Track 8-4Varicella (chickenpox) Vaccine
  • Track 8-5Shingles Vaccine
  • Track 8-6Yellow Fever Vaccine
  • Track 8-7Adenovirus Oral Vaccine
  • Track 8-8Vaccinia (Smallpox) Vaccine
  • Track 9-1Vaccine safety communication
  • Track 9-2HPV Vaccine safety and tolerability
  • Track 9-3Post marketing surveillance of Vaccines
  • Track 9-4Vaccine Pharmacovigilance
  • Track 10-1Animal models in vaccine development
  • Track 10-2Immune Cells responsiveness
  • Track 10-3Clinical manifestation and IgE recognition
  • Track 10-4Emerging clinical trials
  • Track 11-1Advances in DNA Vaccines, TLRS and Combination Adjuvants
  • Track 11-2Next-Generation Adjuvants
  • Track 11-3Nanopatch Technologies
  • Track 12-1Immunization and its side effects in geriatrics
  • Track 12-2Vaccine dosing and administration in older adults
  • Track 12-3Risk factors in geriatric immunization
  • Track 13-1Clinical and Cellular Immunology
  • Track 13-2Tumor and Cancer Immunology
  • Track 13-3Neuro Immunology
  • Track 13-4Autoimmunity and Therapathies
  • Track 13-5Allergy & Asthma
  • Track 13-6Antibodies and Bio Therapeutics
  • Track 14-1Immunity to Infection
  • Track 14-2Immunity to Bacteria & fungi
  • Track 14-3Immunity to viruses
  • Track 14-4Microbial Immunology
  • Track 15-1Recombinant Vaccines
  • Track 15-2Delivery methods
  • Track 17-1Pre-clinical research
  • Track 17-2Phases of Clinical trials
  • Track 17-3Randomization Process
  • Track 17-4Ethical Issues
  • Track 17-5Clinical data management
  • Track 17-6Post Marketing Surveillance
  • Track 18-1Dermatology Clinical trials
  • Track 18-2Clinical trials in Cardiology
  • Track 18-3Clinical trials in Dementia
  • Track 18-4Clinical Trials in Infections and Infectious Diseases
  • Track 18-5Clinical Trials on Genetic Diseases
  • Track 18-6Rare Diseases Clinical trials
  • Track 18-7Clinical Trials in Respiratory Diseases
  • Track 19-1Basic Design & Statistical concepts
  • Track 19-2Design for Cancer clinical trials
  • Track 19-3Efficacy & safety assessment
  • Track 19-4Sequential Designs and concepts
  • Track 20-1Case report form(CRF)
  • Track 20-2CRF Development Process